News
SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...
UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback